Eric Schmidt FCA
Stock Analyst at Cantor Fitzgerald
(4.86)
# 344
Out of 4,352 analysts
40
Total ratings
50%
Success rate
87.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Eric Schmidt FCA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LONA LeonaBio | Reiterated: Buy | n/a | $9.66 | - | 2 | Apr 7, 2026 | |
| GENB Generate Biomedicines | Initiated Coverage: Buy | n/a | $13.12 | - | 1 | Mar 24, 2026 | |
| SRRK Scholar Rock Holding | Maintained: Buy | n/a | $49.30 | - | 2 | Mar 19, 2026 | |
| LEGN Legend Biotech | Maintained: Buy | $75 → $74 | $27.16 | +172.46% | 4 | Dec 17, 2025 | |
| VSTM Verastem | Initiated Coverage: Buy | n/a | $4.33 | - | 1 | Oct 16, 2025 | |
| ALMS Alumis | Reiterated: Buy | n/a | $21.60 | - | 3 | Aug 14, 2025 | |
| BBIO BridgeBio Pharma | Initiated Coverage: Buy | n/a | $66.26 | - | 1 | Aug 13, 2025 | |
| BBOT BridgeBio Oncology Therapeutics | Initiated Coverage: Buy | n/a | $8.97 | - | 1 | Aug 13, 2025 | |
| SMMT Summit Therapeutics | Reiterated: Buy | n/a | $17.54 | - | 8 | Jul 28, 2025 | |
| IMVT Immunovant | Reiterated: Buy | n/a | $33.30 | - | 1 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $10.18 | - | 2 | Jun 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $11.51 | - | 3 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $29.40 | n/a | 3 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $20.65 | n/a | 1 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $311 → $206 | $196.00 | n/a | 3 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $3.40 | n/a | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $96.74 | n/a | 1 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $21.98 | n/a | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $28.89 | n/a | 1 | Nov 2, 2023 |
LeonaBio
Apr 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.66
Upside: -
Generate Biomedicines
Mar 24, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $13.12
Upside: -
Scholar Rock Holding
Mar 19, 2026
Maintained: Buy
Price Target: n/a
Current: $49.30
Upside: -
Legend Biotech
Dec 17, 2025
Maintained: Buy
Price Target: $75 → $74
Current: $27.16
Upside: +172.46%
Verastem
Oct 16, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $4.33
Upside: -
Alumis
Aug 14, 2025
Reiterated: Buy
Price Target: n/a
Current: $21.60
Upside: -
BridgeBio Pharma
Aug 13, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $66.26
Upside: -
BridgeBio Oncology Therapeutics
Aug 13, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $8.97
Upside: -
Summit Therapeutics
Jul 28, 2025
Reiterated: Buy
Price Target: n/a
Current: $17.54
Upside: -
Immunovant
Jul 25, 2025
Reiterated: Buy
Price Target: n/a
Current: $33.30
Upside: -
Jun 20, 2025
Reiterated: Hold
Price Target: n/a
Current: $10.18
Upside: -
Jun 2, 2025
Reiterated: Buy
Price Target: n/a
Current: $11.51
Upside: -
May 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $29.40
Upside: n/a
Mar 21, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $20.65
Upside: n/a
Feb 5, 2025
Maintained: Buy
Price Target: $311 → $206
Current: $196.00
Upside: n/a
May 30, 2024
Initiated Coverage: Buy
Price Target: n/a
Current: $3.40
Upside: n/a
Apr 23, 2024
Initiated Coverage: Hold
Price Target: n/a
Current: $96.74
Upside: n/a
Apr 4, 2024
Initiated Coverage: Buy
Price Target: n/a
Current: $21.98
Upside: n/a
Nov 2, 2023
Initiated Coverage: Buy
Price Target: n/a
Current: $28.89
Upside: n/a